ReviewPerioperative medicine (London, England)2026
Effects of perioperative tight glycemic control on prognosis in diabetic abdominal surgery patients: a systematic review and meta-analysis.
Review in Perioperative medicine (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundAsian studies presents conflicting conclusions regarding the prognostic benefits of perioperative tight glycemic control (TGC) versus conventional glycemic control (CGC) in abdominal surgery. This systematic review and meta-analysis synthesizes current evidence to resolve these clinical discrepancies.
methodsA systematic search across major databases (PubMed, Web of Science, EMBASE, Cochrane, etc.) identified randomized controlled trials assessing perioperative TGC’s impact on abdominal surgery patient prognosis.
resultsThis meta-analysis, encompassing 30 studies with 2,709 patients, demonstrates that perioperative TGC significantly reduces the incidence of surgical site infections, respiratory tract infections, overall complications, and hypoglycemia in patients undergoing abdominal surgery. While publication bias was noted for overall complications and heterogeneity for hypoglycemia, neither affected the conclusions. TGC’s potential to reduce wound healing time and hospital stay is attenuated by publication bias, while the conclusion on length of stay is further confounded by significant data heterogeneity. No difference was observed in the incidence of urinary tract infections.
conclusionCompared to perioperative CGC, perioperative TGC, which maintains blood glucose levels at 4.44–6.67 mmol/L, can significantly improve the prognosis of patients undergoing abdominal surgery.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.